|  Help  |  About  |  Contact Us

Publication : THEMIS attenuates MASH by suppressing disease-associated hepatocyte induction and hepatocyte senescence in mice.

First Author  Qiu X Year  2026
Journal  J Clin Invest Volume  136
Issue  9 PubMed ID  42065240
Mgi Jnum  J:387089 Mgi Id  MGI:8329443
Doi  10.1172/JCI199303 Citation  Qiu X, et al. (2026) THEMIS attenuates MASH by suppressing disease-associated hepatocyte induction and hepatocyte senescence in mice. J Clin Invest 136(9)
abstractText  Hepatocyte senescence is increasingly recognized as a pathogenic driver of metabolic dysfunction-associated steatohepatitis (MASH). Through single-nucleus transcriptomic profiling, we identified a discrete population of disease-associated hepatocytes (daHep) exhibiting enrichment for senescence markers in MASH livers. The emergence of senescent hepatocytes was associated with a marked induction of hepatic thymocyte selection associated (THEMIS) expression in both murine and human MASH. Genetic ablation of Themis, either globally or specifically in hepatocytes, resulted in significant expansion of daHep and senescent hepatocyte populations and exacerbated MASH pathology in mice. Single-nucleus transcriptomic analysis revealed a central role for THEMIS in shaping the cellular landscape of both parenchymal and nonparenchymal compartments within the MASH liver microenvironment. Conversely, adeno-associated virus-mediated overexpression of THEMIS suppressed hepatocyte senescence and attenuated diet-induced MASH. Mechanistic studies revealed that THEMIS deficiency promoted aberrant ERK phosphorylation and hepatocyte senescence. These findings establish THEMIS as a critical hepatoprotective factor that restrains hepatocyte senescence and mitigates metabolic liver disease progression.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

6 Bio Entities

Trail: Publication

0 Expression